We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+0.2%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.9B
AUM Growth
-$1.94B
Cap. Flow
-$1.04B
Cap. Flow %
-4.99%
Top 10 Hldgs %
40.27%
Holding
168
New
18
Increased
43
Reduced
28
Closed
22

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$381M
2
MSFT icon
Microsoft
MSFT
+$266M
3
CRM icon
Salesforce
CRM
+$235M
4
K
Kellanova
K
+$186M
5
ARMK icon
Aramark
ARMK
+$178M

Top Sells

Rank Stock Value
1
ABNB icon
Airbnb
ABNB
+$319M
2
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$221M
3
AON icon
Aon
AON
+$181M
4
BMY icon
Bristol-Myers Squibb
BMY
+$180M
5
HES
Hess
HES
+$150M

Sector Composition

Rank Sector Weight
1 Healthcare 37.95%
2 Technology 14.96%
3 Financials 12.32%
4 Communication Services 7.9%
5 Industrials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
126
Pacific Biosciences
PACB
$370M
$159K ﹤0.01%
135,000
– –
QURE icon
127
uniQure
QURE
$3.22B
$148K ﹤0.01%
+14,000
New +$196K
OSCR icon
128
Oscar Health
OSCR
$8.61B
$144K ﹤0.01%
11,000
– –
ALT icon
129
Altimmune
ALT
$599M
$138K ﹤0.01%
27,600
– –
EVH icon
130
Evolent Health
EVH
$447M
$133K ﹤0.01%
14,000
– –
FOLD
131
DELISTED
Amicus Therapeutics
FOLD
$131K ﹤0.01%
16,000
– –
SNDX icon
132
Syndax Pharmaceuticals
SNDX
$1.82B
$123K ﹤0.01%
10,000
– –
ARDX icon
133
Ardelyx
ARDX
$997M
$113K ﹤0.01%
23,000
– –
DYN icon
134
Dyne Therapeutics
DYN
$4.9B
$105K ﹤0.01%
10,000
-219,121
-96% -$3.13M
NVAX icon
135
Novavax
NVAX
$1.31B
$103K ﹤0.01%
16,000
– –
COGT icon
136
Cogent Biosciences
COGT
$7.24B
$102K ﹤0.01%
17,000
– –
IOVA icon
137
Iovance Biotherapeutics
IOVA
$2.87B
$86.6K ﹤0.01%
26,000
– –
SLDPW icon
138
Solid Power Inc Warrant
SLDPW
$10.6M
$68.9K ﹤0.01%
405,316
– –
GERN icon
139
Geron
GERN
$949M
$68.4K ﹤0.01%
43,000
– –
BYSI icon
140
BeyondSpring
BYSI
$35.8M
$58K ﹤0.01%
+19,000
New +$32K
CCCC icon
141
C4 Therapeutics
CCCC
$412M
$44.8K ﹤0.01%
28,000
– –
ANNA
142
AleAnna Inc
ANNA
$105M
$35K ﹤0.01%
78,400
– –
CGC
143
Canopy Growth
CGC
$410M
$27.3K ﹤0.01%
30,000
– –
IRWD icon
144
Ironwood Pharmaceuticals
IRWD
$714M
$19.1K ﹤0.01%
13,000
– –
NVNIW
145
Nvni Group Limited Warrants
NVNIW
$836K
$10.7K ﹤0.01%
375,000
– –
RVMDW icon
146
Revolution Medicines Inc Warrant
RVMDW
$127M
$4.56K ﹤0.01%
120,085
– –
ABNB icon
147
Airbnb
ABNB
$107B
– –
-2,429,200
Closed -$319M
ASHR icon
148
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
– –
-1,020,000
Closed -$27M
BMY icon
149
Bristol-Myers Squibb
BMY
$132B
– –
-3,188,000
Closed -$180M
ELEV
150
DELISTED
Elevation Oncology
ELEV
– –
-3,527,482
Closed -$1.98M
3 4 5
6
7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Farallon Capital Management held 168 positions worth $20.9B, down 8.5% from $22.8B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Farallon Capital Management withdrew a net $1.04B in Q1 2025, closing 22 positions and reducing 28 holdings. Its most notable exit was Airbnb, an estimated $319M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 34% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $403M.

  • Farallon Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 3,055,000 shares worth $403M.
  • Farallon Capital Management added most to Microsoft in Q1 2025, an estimated $266M increase.
  • Farallon Capital Management's biggest Q1 2025 reduction was Aon, cutting an estimated $181M.
  • Farallon Capital Management fully exited Airbnb in Q1 2025, selling an estimated $319M.
  • Farallon Capital Management's ten largest holdings make up 40% of its $20.9B portfolio in Q1 2025.
  • Farallon Capital Management opened 18 new positions and closed 22 in Q1 2025.
  • Farallon Capital Management's portfolio value fell 8.5% quarter-over-quarter to $20.9B.

Based on Farallon Capital Management's 13F filing for Q1 2025, filed 15 May 2025.